The total return over the past 12 months is +37.68% vs. +16.94% for the S&P 500. So far it's up +35.05% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +37.68% | +55.17% | (10.57%) | N/A | N/A | N/A |
| Total Return CAGR | +37.68% | +55.17% | (10.57%) | N/A | N/A | N/A |
| Revenue CAGR | (100.00%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Entera Bio Ltd. (ENTX)
| Year | Start price | End price | ENTX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.94 | $2.62 | +35.05% | +14.51% | +20.54% |
| 2025 | $2.12 | $1.94 | (8.49%) | +17.72% | (26.21%) |
| 2024 | $0.60 | $2.12 | +253.33% | +24.89% | +228.44% |
| 2023 | $0.73 | $0.60 | (17.81%) | +26.19% | (44.00%) |
| 2022 | $2.82 | $0.73 | (74.11%) | (18.17%) | (55.94%) |
| 2021 | $1.08 | $2.82 | +161.11% | +28.74% | +132.37% |
| 2020 | $2.14 | $1.08 | (49.53%) | +18.37% | (67.90%) |
| 2019 | $3.05 | $2.14 | (29.84%) | +31.22% | (61.06%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
